BoomRx Achieves Major Milestones with $15.5 Million in Revenue in Just 8 Months BoomRx has rapidly grown to achieve $15.5 million in net order revenue and over 77,000 orders processed in just eight months, transforming prescription sourcing.

BoomRx Achieves Major Milestones with $15.5 Million in Revenue in Just 8 Months #USA #Tampa #Health_Tech #Pharmaceutical_Technology #BoomRx

ACTO's CxZone Achieves Unprecedented Recognition at 2025 Pharmaceutical Excellence Awards ACTO's groundbreaking solution, CxZone, wins two prestigious awards at the Pharmaceutical Technology Excellence Awards 2025, showcasing innovation in AI roleplay.

ACTO's CxZone Achieves Unprecedented Recognition at 2025 Pharmaceutical Excellence Awards #USA #AI_Roleplay #Toronto,_New_York #Pharmaceutical_Technology #ACTO_CxZone

ACTO's CXZone Redefines Pharmaceutical Training with Dual Honors in 2025 Excellence Awards ACTO's CXZone has achieved remarkable recognition in the 2025 Pharmaceutical Technology Excellence Awards, showcasing its innovative AI roleplay solution for field professionals.

ACTO's CXZone Redefines Pharmaceutical Training with Dual Honors in 2025 Excellence Awards #USA #ACTO #Toronto_and_New_York #CxZone #Pharmaceutical_Technology

ACTO's CxZone Shines with Dual Recognition at 2025 Pharmaceutical Excellence Awards ACTO's innovative AI-simulated roleplay solution, CxZone, has been honored twice at the 2025 Pharmaceutical Technology Excellence Awards, showcasing groundbreaking advancements in pharmaceutical training.

ACTO's CxZone Shines with Dual Recognition at 2025 Pharmaceutical Excellence Awards #ACTO #CxZone #Pharmaceutical_Technology